An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug – Paxlovid – is intended for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it stopped trials early as the initial results were so positive.
It comes the day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Please subscribe HERE http://bit.ly/1rbfUog
#Covid #BBCNews
L'edizione della notte del Tg diretto da Enrico Mentana
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
Andrew Mountbatten-Windsor appears to have knowingly shared confidential information with Jeffrey Epstein when, as Prince Andrew, he was a UK…
MILANO (ITALPRESS) – Si chiude con un altro capolavoro a tinte azzurre, una giornata storica per il mondo dello sport…
TORINO (ITALPRESS) – Kalulu salva in extremis la Juventus nel giorno in cui l’Allianz Stadium festeggia il rinnovo fino al…